NDC Package 66302-206-01 Tyvaso

Treprostinil Inhalant Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
66302-206-01
Package Description:
1 BOX in 1 KIT / 28 AMPULE in 1 BOX / 2.9 mL in 1 AMPULE
Product Code:
Proprietary Name:
Tyvaso
Non-Proprietary Name:
Treprostinil
Substance Name:
Treprostinil
Usage Information:
This medication is used to treat a type of high blood pressure in the lungs (pulmonary arterial hypertension). Treprostinil helps to increase your ability to exercise and improves symptoms such as shortness of breath and tiredness. It works by relaxing and widening the blood vessels (arteries) in the lungs and other parts of the body so that blood can flow more easily. This medication belongs to a class of drugs known as vasodilators.
11-Digit NDC Billing Format:
66302020601
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 857795 - treprostinil 1.74 MG/2.9 ML (0.6 MG/ML) Inhalation Solution
  • RxCUI: 857795 - treprostinil 0.6 MG/ML Inhalation Solution
  • RxCUI: 857799 - TYVASO 1.74 MG/2.9 ML (0.6 MG/ML) Inhalation Solution
  • RxCUI: 857799 - treprostinil 0.6 MG/ML Inhalation Solution [Tyvaso]
  • RxCUI: 857799 - Tyvaso 0.6 MG/ML Inhalation Solution
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    United Therapeutics Corporation
    Dosage Form:
    Inhalant - A special class of inhalations consisting of a drug or combination of drugs, that by virtue of their high vapor pressure can be carried by an air current into the nasal passage where they exert their effect; the container from which the inhalant generally is administered is known as an inhaler.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    NDA022387
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    08-14-2009
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 66302-206-01 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    66302020601J7686Treprostinil, non-comp unit1.74 MG2.928128

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    66302-206-021 BOX in 1 KIT / 28 AMPULE in 1 BOX / 2.9 mL in 1 AMPULE
    66302-206-034 AMPULE in 1 BOX / 2.9 mL in 1 AMPULE
    66302-206-041 BOX in 1 KIT / 4 AMPULE in 1 BOX / 2.9 mL in 1 AMPULE

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 66302-206-01?

    The NDC Packaged Code 66302-206-01 is assigned to a package of 1 box in 1 kit / 28 ampule in 1 box / 2.9 ml in 1 ampule of Tyvaso, a human prescription drug labeled by United Therapeutics Corporation. The product's dosage form is inhalant and is administered via oral form.

    Is NDC 66302-206 included in the NDC Directory?

    Yes, Tyvaso with product code 66302-206 is active and included in the NDC Directory. The product was first marketed by United Therapeutics Corporation on August 14, 2009 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 66302-206-01?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 66302-206-01?

    The 11-digit format is 66302020601. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-266302-206-015-4-266302-0206-01